Behnke D - Search Results

1

Association of time to recurrence with thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression in stage II and III colorectal cancer.

Kornmann M, Link KH, Galuba I, Ott K, Schwabe W, Häusler P, Scholz P, Sträter J, Polat S, Leibl B, Kettner E, Schlichting C, Baumann W, Schramm H, Hecker U, Ridwelski K, Vogt JH, Zerbian KU, Schütze F, Kreuser ED, Behnke D, Beger HG. Kornmann M, et al. Among authors: behnke d. J Gastrointest Surg. 2002 May-Jun;6(3):331-7. doi: 10.1016/s1091-255x(02)00018-5. J Gastrointest Surg. 2002. PMID: 12022983

2

Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.

Kornmann M, Schwabe W, Sander S, Kron M, Sträter J, Polat S, Kettner E, Weiser HF, Baumann W, Schramm H, Häusler P, Ott K, Behnke D, Staib L, Beger HG, Link KH. Kornmann M, et al. Among authors: behnke d. Clin Cancer Res. 2003 Sep 15;9(11):4116-24. Clin Cancer Res. 2003. PMID: 14519634

3

Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls.

Raida M, Schwabe W, Häusler P, Van Kuilenburg AB, Van Gennip AH, Behnke D, Höffken K. Raida M, et al. Among authors: behnke d. Clin Cancer Res. 2001 Sep;7(9):2832-9. Clin Cancer Res. 2001. PMID: 11555601

4

Circadian variation of dihydropyrimidine dehydrogenase mRNA expression in leukocytes and serum cortisol levels in patients with advanced gastrointestinal carcinomas compared to healthy controls.

Raida M, Kliche KO, Schwabe W, Häusler P, Clement JH, Behnke D, Höffken K. Raida M, et al. Among authors: behnke d. J Cancer Res Clin Oncol. 2002 Feb;128(2):96-102. doi: 10.1007/s00432-001-0309-y. Epub 2001 Nov 30. J Cancer Res Clin Oncol. 2002. PMID: 11862480

5

High-level mRNA quantification of proliferation marker pKi-67 is correlated with favorable prognosis in colorectal carcinoma.

Ihmann T, Liu J, Schwabe W, Häusler P, Behnke D, Bruch HP, Broll R, Windhövel U, Duchrow M. Ihmann T, et al. Among authors: behnke d. J Cancer Res Clin Oncol. 2004 Dec;130(12):749-56. doi: 10.1007/s00432-004-0612-5. Epub 2004 Sep 21. J Cancer Res Clin Oncol. 2004. PMID: 15449182

6

Pharmacokinetics of 5-fluorouracil in patients heterozygous for the IVS14+1G > A mutation in the dihydropyrimidine dehydrogenase gene.

van Kuilenburg AB, Maring JG, Schalhorn A, Terborg C, Schmalenberg H, Behnke D, Schwabe W, Jabschinsky K, Hausler P. van Kuilenburg AB, et al. Among authors: behnke d. Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):692-8. doi: 10.1080/15257770802145009. Nucleosides Nucleotides Nucleic Acids. 2008. PMID: 18600527

7

Evaluation of 5-fluorouracil pharmacokinetics in cancer patients with a c.1905+1G>A mutation in DPYD by means of a Bayesian limited sampling strategy.

van Kuilenburg AB, Häusler P, Schalhorn A, Tanck MW, Proost JH, Terborg C, Behnke D, Schwabe W, Jabschinsky K, Maring JG. van Kuilenburg AB, et al. Among authors: behnke d. Clin Pharmacokinet. 2012 Mar 1;51(3):163-74. doi: 10.1007/BF03257473. Clin Pharmacokinet. 2012. PMID: 22339448

8

Comparison of mRNA expression levels determined with TaqMan and competitive template RT-PCR.

Mauritz R, Schwabe W, Haeusler P, Noordhuis P, Smid K, McLeod HL, Behnke D, van Groeningen CJ, Peters GJ. Mauritz R, et al. Among authors: behnke d. Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1471-4. doi: 10.1081/NCN-200027689. Nucleosides Nucleotides Nucleic Acids. 2004. PMID: 15571279

9

Phase 1 trial of the novel bispecific molecule H22xKi-4 in patients with refractory Hodgkin lymphoma.

Borchmann P, Schnell R, Fuss I, Manzke O, Davis T, Lewis LD, Behnke D, Wickenhauser C, Schiller P, Diehl V, Engert A. Borchmann P, et al. Among authors: behnke d. Blood. 2002 Nov 1;100(9):3101-7. doi: 10.1182/blood-2001-12-0295. Blood. 2002. PMID: 12384405 Free article. Clinical Trial.

10

Bispecific antibody-mediated destruction of Hodgkin's lymphoma cells.

Sundarapandiyan K, Keler T, Behnke D, Engert A, Barth S, Matthey B, Deo YM, Graziano RF. Sundarapandiyan K, et al. Among authors: behnke d. J Immunol Methods. 2001 Feb 1;248(1-2):113-23. doi: 10.1016/s0022-1759(00)00347-1. J Immunol Methods. 2001. PMID: 11223073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page